Suspended

Measures of Free Radical Damage and Antioxidant Activity in Amyotrophic Lateral Sclerosis

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Central Nervous System Diseases+15

+ Metabolic Diseases

+ Nervous System Diseases

Over 18 Years
See all eligibility criteria
How is the trial designed

Defined Population

Following a specific population over time in order to understand disease trends and health outcomes within that group.
Observational
Study Start: March 1998
See protocol details

Summary

Principal SponsorNational Institute of Neurological Disorders and Stroke (NINDS)
Last updated: June 24, 2005
Sourced from a government-validated database.Claim as a partner

Study start date: March 1, 1998

Actual date on which the first participant was enrolled.

PROTOCOL OUTLINE: This is a screening and diagnostic study. Blood and urine samples are collected from patients every 2 months for 1 year. All samples are evaluated for measures of free radical damage and levels of the body's own antioxidant activity.

NCT00004457
Principal SponsorNational Institute of Neurological Disorders and Stroke (NINDS)
Last updated: June 24, 2005
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

75 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Defined Population

Researchers follow a specific group of people—such as residents of a region or members of an organization—over time. The goal is to track disease patterns and health outcomes in a defined setting.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Central Nervous System DiseasesMetabolic DiseasesNervous System DiseasesNeuromuscular DiseasesNutritional and Metabolic DiseasesPathologic ProcessesSigns and SymptomsSpinal Cord DiseasesPathological Conditions, Signs and SymptomsNeurodegenerative DiseasesDisease AttributesProteostasis DeficienciesTDP-43 ProteinopathiesAmyotrophic Lateral SclerosisMental DisordersNeurologic ManifestationsMotor Neuron DiseaseRare Diseases

Criteria

PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- Clinically diagnosed probable or definite, sporadic or familial amyotrophic lateral sclerosis --Patient Characteristics-- Pulmonary: No artificial ventilation required Other: No other neurodegenerative diseases No concurrent or history of unstable medical illness

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has no location dataSave this study to your profile to know when the location data is available.
SuspendedNo study centers